Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2

Status

Completed 5Unknown 4Recruiting 4Not yet recruiting 3Withdrawn 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2Lymphoid 1

Conditions

Breast Neoplasms 10Neoplasms 9Polycystic Ovary Syndrome 8Infertility 5Liver Neoplasms 4Pain, Postoperative 3Neoplasm Metastasis 3Multiple Myeloma 3Lung Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Recurrence 2Pulmonary Embolism 2Prostatic Neoplasms 2Pleural Effusion 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neuroma, Acoustic 2Melanoma 2Lymphoma, Follicular 2Leiomyoma 2Inflammation 2Febrile Neutropenia 2Colorectal Neoplasms 2Bites and Stings 2Anovulation 2Vomiting 1Venous Thrombosis 1Venous Thromboembolism 1

Interventions

ceftolozane, tazobactam drug combination 1Micafungin 1Meropenem 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Withdrawn × Febrile Neutropenia × Clear all
NCT05784844 2024-09-19

Antimicrobial Revision in Persistent Febrile Neutropenia

Wake Forest University Health Sciences

Phase 4 Withdrawn
Classical hematologyLymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT05061654 2023-08-14

CEF-10

Hamad Medical Corporation

Phase 4 Withdrawn
Classical hematologyOther hematologic neoplasm

Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡